ePoster 2019
DOI: 10.1136/ijgc-2019-esgo.588
|View full text |Cite
|
Sign up to set email alerts
|

EP530 Indocyanine green in surgical staging of early stage endometrial cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 0 publications
0
2
0
1
Order By: Relevance
“…Також є багато досліджень щодо використання методу маркування СЛВ у низьких [41,42] та високих [43,44] групах ризику метастазування. У ретроспективному дослідженні M. Bedyńska [47].…”
Section: рак ендометріяunclassified
“…Також є багато досліджень щодо використання методу маркування СЛВ у низьких [41,42] та високих [43,44] групах ризику метастазування. У ретроспективному дослідженні M. Bedyńska [47].…”
Section: рак ендометріяunclassified
“…The combined pathology of the endometrium and myometrium is observed in 40-55% of premenopausal women, while 40% of women with uterine fibroids, adenomyosis, and 80% of women with endometrial hyperplasia (EH) develop abnormal uterine bleeding (AUB) [1].…”
mentioning
confidence: 99%
“…The frequency of EH relapses and menstrual dysfunction against the background of combined endometrial and myometrial hyperproliferative pathology after hormonal treatment remains quite high. Given the increased risk of malignancy in premenopause, the issue of early diagnosis and individualized treatment does not lose its relevance [1][2][3][4].…”
mentioning
confidence: 99%